Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Autoimmune

Advertisement

Featured Stories

News
Comparing Onset of Action of Therapies in Rheumatoid Arthritis
11/16/2024
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to...
11/16/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
ASAS Issues Consensus Recommendations for Imaging in axSpA
10/10/2024
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines...
10/10/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Study Identifies Most Discriminative Ultrasound Lesions for Spondyloarthritis
09/11/2024
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was...
09/11/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Subcutaneous Ustekinumab Cost Rose 84% Under Medicare Part D, Set to Drop Under Negotiated Price Reduction
08/15/2024
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted...
08/15/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Unvaccinated Patients With Rheumatic Diseases Risked Severe COVID-19
08/07/2024
Throughout the pandemic, patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes.
Throughout the pandemic, patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes.
Throughout the pandemic,...
08/07/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Car-T Cell Treatment in Refractory Autoimmune Disease
07/12/2024
CD19 CAR-T cell treatment shows long-term safety and efficacy in 3 different autoimmune diseases.
CD19 CAR-T cell treatment shows long-term safety and efficacy in 3 different autoimmune diseases.
CD19 CAR-T cell treatment shows...
07/12/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Ultraprocessed Food Intake and SLE Incidence Among Women
07/12/2024
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially...
07/12/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
SpA Screening Tools Not Applicable to All Patients With Extramusculoskeletal Symptoms
05/08/2024
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening...
05/08/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
Poll
Poll: Gout Among Older Adults
04/22/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
What has contributed to suboptimal serum urate monitoring among older adults with gout? Tell us what you think by taking our quick poll.
What has contributed to suboptimal serum urate monitoring among older adults with gout? Tell us what you think by taking our quick poll.
What has contributed to...
04/22/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
Quiz
Body Mass Index and the Risk of Rheumatic Diseases
03/14/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity...
03/14/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
IL-17 and IL-23 Inhibitor Infection Risk Low in PsA, PsO
03/04/2024
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the...
03/04/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Meetings & Publications

Advertisement

Case Reports

Case Report
Sjögren Syndrome: Clinical Manifestations, Diagnosis, and Management
07/29/2019
Sjögren syndrome (SS) is a systemic autoimmune disease characterized mainly by the presence of keratoconjunctivitis sicca and xerostomia. Patients also may experience inflammation of the joints, muscles, nerves, lungs, gastrointestinal tract,...
Sjögren syndrome (SS) is a systemic autoimmune disease characterized mainly by the presence of keratoconjunctivitis sicca and xerostomia. Patients also may experience inflammation of the joints, muscles, nerves, lungs, gastrointestinal tract,...
Sjögren syndrome (SS) is a...
07/29/2019
Rheumatology & Arthritis
Case Report
Renal Infarction in Ehlers-Danlos Syndrome
07/24/2019
Authors: Kohli Maanit, MD, and Balaji Yegneswaran, MD Saint Peter’s University Hospital, New Brunswick, New Jersey Citation: Maanit K, Yegneswaran B. Renal infarction in Ehlers-Danlos syndrome. Consultant....
Authors: Kohli Maanit, MD, and Balaji Yegneswaran, MD Saint Peter’s University Hospital, New Brunswick, New Jersey Citation: Maanit K, Yegneswaran B. Renal infarction in Ehlers-Danlos syndrome. Consultant....
...
07/24/2019
Rheumatology & Arthritis
Case Report
Do Antibiotics Have a Role in the Pathogenesis of Juvenile Arthritis?
11/23/2015
It is apparent that disruption of the human microbiome can play a role in the development of chronic pediatric diseases such as inflammatory bowel disease and juvenile idiopathic arthritis (JIA). What has not been fully explored are the...
It is apparent that disruption of the human microbiome can play a role in the development of chronic pediatric diseases such as inflammatory bowel disease and juvenile idiopathic arthritis (JIA). What has not been fully explored are the...
It is apparent that disruption...
11/23/2015
Rheumatology & Arthritis

Advertisement

Videos

Conference Coverage
Rebecca Haberman, MD, on Racial and Ethnic Determinants of Psoriatic Phenotypes and Disease Activity
01/02/2024
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a...
01/02/2024
Rheumatology & Arthritis
Videos
Laura Coates, MBBS, on the Safety of Risankizumab for Psoriatic Disease
11/12/2023
Dr Laura Coates reviews research she and colleagues conducted on the safety of risankizumab for the treatment of psoriatic arthritis and psoriasis.
Dr Laura Coates reviews research she and colleagues conducted on the safety of risankizumab for the treatment of psoriatic arthritis and psoriasis.
Dr Laura Coates reviews research...
11/12/2023
Rheumatology & Arthritis
Vikas Majithia
Video
Vikas Majithia, MD, on Nonradiographic Axial Spondyloarthritis
05/23/2023
Dr Majithia, from Mayo Clinic-Florida, clarifies differences and similarities between radiographic and nonradiographic axial spondyloarthritis.
Dr Majithia, from Mayo Clinic-Florida, clarifies differences and similarities between radiographic and nonradiographic axial spondyloarthritis.
Dr Majithia, from Mayo...
05/23/2023
Rheumatology & Arthritis
Gil Melmed, MD
Conference Coverage
Gil Melmed, MD, on COVID-19 Vaccination Responses and Safety in Patients with IBD
12/21/2022
Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.
Dr Melmed reviews the results of studies regarding the response to and safety of COVID-19 vaccination among patients with IBD.
Dr Melmed reviews the results of...
12/21/2022
Autoimmune
Walter Maksymowych
Conference Coverage
Walter Maksymowych, MD, on Upadacitinib in Axial Spondyloarthritis
12/13/2022
Dr Maksymowych discusses the results of a randomized clinical trial of upadacitinib vs placebo among patients with radiographic and nonradiographic axial spondyloarthritis.
Dr Maksymowych discusses the results of a randomized clinical trial of upadacitinib vs placebo among patients with radiographic and nonradiographic axial spondyloarthritis.
Dr Maksymowych discusses the...
12/13/2022
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
Alexis Ogdie, MD, on Response Rates in PsA: Results from the KEEPsAKE Trials of Risankizumab
11/14/2022
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of...
11/14/2022
Rheumatology & Arthritis
Alfred Kim
Video
Alfred Kim, MD, on COVID-19 Pre-exposure Prophylaxis for Patients with Autoimmune Disease
11/01/2022
Dr Kim, from Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, Missouri, reviews the importance of PrEP in protecting patients on immune-suppressing drugs.
Dr Kim, from Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, Missouri, reviews the importance of PrEP in protecting patients on immune-suppressing drugs.
Dr Kim, from Washington...
11/01/2022
Rheumatology & Arthritis
Michelle Petri
Video
Michelle Petri, MD, on Improving Outcomes in SLE by Individualizing Care
04/23/2022
Dr Petri, from Johns Hopkins University, reviews her presentation at the Interdisciplinary Autoimmune Summit on the importance of providing individualized care for patients with systemic lupus erythematosus.
Dr Petri, from Johns Hopkins University, reviews her presentation at the Interdisciplinary Autoimmune Summit on the importance of providing individualized care for patients with systemic lupus erythematosus.
Dr Petri, from Johns Hopkins...
04/23/2022
Rheumatology & Arthritis
Al Kim
Video
Alfred Kim, MD, on the Immunogenicity of Vaccine Responses Among Patients With Rheumatic Diseases
12/06/2021
Dr Kim, from Washington University School of Medicine, discusses recent research he presented at the ACR Convergence demonstrating how patients on various immunosuppressive therapies respond to vaccines—including the vaccine against...
Dr Kim, from Washington University School of Medicine, discusses recent research he presented at the ACR Convergence demonstrating how patients on various immunosuppressive therapies respond to vaccines—including the vaccine against...
Dr Kim, from Washington...
12/06/2021
Rheumatology & Arthritis
Dermatology
Dr John Harris Discusses Vitiligo and the Most Common Comorbidities of the Disease
06/21/2021
Vitiligo, an autoimmune disease of the skin, can be debilitating for patients. While more study is needed to better understand relationships, John Harris, MD, PhD, details the most common comorbidities of vitiligo. Dr Harris is the chair of...
Vitiligo, an autoimmune disease of the skin, can be debilitating for patients. While more study is needed to better understand relationships, John Harris, MD, PhD, details the most common comorbidities of vitiligo. Dr Harris is the chair of...
Vitiligo, an autoimmune disease...
06/21/2021
Autoimmune

Advertisement

Q&As

Monica Schwartzman
Q&A
Monica Schwartzman, MD, on Medication Preferences Among Patients With PsA
08/21/2023
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our...
08/21/2023
Rheumatology & Arthritis
Alexis Ogdie
Q&A
Alexis Ogdie, MD, on a Treat To Target Approach to Psoriatic Arthritis
06/29/2022
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving...
06/29/2022
Rheumatology & Arthritis
Joshua Baker, MD
Q&As
Elevations in Adipocytokines and Mortality in Rheumatoid Arthritis
04/21/2022
Joshua Baker, MD, from the Perelman School of Medicine at the University of Pennsylvania, answers our questions about his recent study into potential links between body mass, obesity, and the risk of death among patients with rheumatoid...
Joshua Baker, MD, from the Perelman School of Medicine at the University of Pennsylvania, answers our questions about his recent study into potential links between body mass, obesity, and the risk of death among patients with rheumatoid...
Joshua Baker, MD, from the...
04/21/2022
Rheumatology & Arthritis
Lianne Gensler
Q&A
Bimekizumab Therapy and Beyond for Ankylosing Spondylitis
02/01/2022
Lianne Gensler, MD, rheumatologist and director of the University of California, San Francisco, Spondyloarthritis Clinic, discussed the role of IL-17 in ankylosing spondylitis (AS) and the use of bimekizumab in treating this disease.
Lianne Gensler, MD, rheumatologist and director of the University of California, San Francisco, Spondyloarthritis Clinic, discussed the role of IL-17 in ankylosing spondylitis (AS) and the use of bimekizumab in treating this disease.
Lianne Gensler, MD,...
02/01/2022
Autoimmune
Celia Mead, Executive Director of BIRD
Q&As
Bath Institute for Rheumatic Diseases: Empowering Psoriatic Arthritis Researchers and Patients Alike
01/11/2022
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director...
01/11/2022
The Dermatologist
Q&As
Dr Joan Merrill: Insights on Anifrolumab
07/12/2021
Joan T. Merrill, MD, discusses her insights into anifrolumab and its benefits in treating moderate to severe systemic lupus erythematosus (SLE).
Joan T. Merrill, MD, discusses her insights into anifrolumab and its benefits in treating moderate to severe systemic lupus erythematosus (SLE).
Joan T. Merrill, MD, discusses...
07/12/2021
The Dermatologist
Jason Schairer, MD, on Dermatologic Manifestations in IBD
Q&As
Jason Schairer, MD, on Dermatologic Manifestations in IBD
06/06/2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
In this Q&A, Dr Schairer answers...
06/06/2021
Autoimmune
Dr Peter Lio on the Relationship Between AD and IMIDs
Q&As
Dr Peter Lio on the Relationship Between AD and IMIDs
04/16/2021
At the Interdisciplinary Autoimmune Summit 2021, Dr Lio spoke about emerging therapies for moderate to severe AD. In an interview with ALN, he answered several questions regarding advanced management of the disease.
At the Interdisciplinary Autoimmune Summit 2021, Dr Lio spoke about emerging therapies for moderate to severe AD. In an interview with ALN, he answered several questions regarding advanced management of the disease.
At the Interdisciplinary...
04/16/2021
The Dermatologist
Computer
Q&As
Q&A: Impact of COVID-19 on Patients With Psoriatic Arthritis
03/04/2021
Joseph F. Merola, MD, MMSc discussed the impact of the COVID-19 pandemic among patients with psoriatic arthritis.
Joseph F. Merola, MD, MMSc discussed the impact of the COVID-19 pandemic among patients with psoriatic arthritis.
Joseph F. Merola, MD, MMSc...
03/04/2021
Autoimmune
Thomas Werfel, MD, on the Safety of Tralokinumab for the Treatment of Atopic Dermatitis
Q&As
Thomas Werfel, MD, on the Safety of Tralokinumab for the Treatment of Atopic Dermatitis
02/11/2021
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
In this Q&A, Thomas Werfel, MD, discussed findings from pooled analyses that investigated the safety of tralokinumab among patients with atopic dermatitis.
In this Q&A, Thomas Werfel, MD,...
02/11/2021
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Podcasts

Len Calabrese
Podcast
Leonard Calabrese, DO, on the Nosology of Long COVID
02/29/2024
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the...
02/29/2024
Rheumatology & Arthritis
Dr Patricia Katz
Podcast
SARS‐CoV‐2 Vaccination Among Immunocompromised Patients Helps Mental Health
01/22/2024
Dr Patricia Katz sheds light on the cohort analysis findings that suggest a positive correlation between mental wellbeing—a common burden among patients with chronic inflammatory diseases—and COVID-19 vaccination.
Dr Patricia Katz sheds light on the cohort analysis findings that suggest a positive correlation between mental wellbeing—a common burden among patients with chronic inflammatory diseases—and COVID-19 vaccination.
Dr Patricia Katz sheds light on...
01/22/2024
Rheumatology & Arthritis
Tate Johnson, MD
Podcast
Tate Johnson, MD, on Aortic Stenosis and Rheumatoid Arthritis
01/11/2024
The risk of cardiovascular diseases among patients with rheumatoid arthritis goes beyond just heart attacks and strokes. Findings of a large cohort study revealed that patients with RA were at a higher risk of developing aortic stenosis—which...
The risk of cardiovascular diseases among patients with rheumatoid arthritis goes beyond just heart attacks and strokes. Findings of a large cohort study revealed that patients with RA were at a higher risk of developing aortic stenosis—which...
The risk of cardiovascular...
01/11/2024
Autoimmune
Shilpa Venkatachalam
Podcast
Patient Attitudes to Online Wellness Programs for Psoriatic Arthritis
10/13/2023
Dr Shilpa Venkatachalam, director of Patient-Centered Research Operations and Ethical Oversight at the Global Healthy Living Foundation, reviews the results of a survey among patients with psoriatic arthritis regarding interest in an online...
Dr Shilpa Venkatachalam, director of Patient-Centered Research Operations and Ethical Oversight at the Global Healthy Living Foundation, reviews the results of a survey among patients with psoriatic arthritis regarding interest in an online...
Dr Shilpa Venkatachalam,...
10/13/2023
Rheumatology & Arthritis
Mohamad Bittar, MD
Podcast
Nonrad AxSpA and the Disease Burden on the Patient
10/05/2023
Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.
Dr Bittar educates the listeners on the core differences and similarities between ankylosing spondylitis and axial spondyloarthritis; and provides guidance on diagnosing and monitoring/ treating patients with various forms of axial diseases.
Dr Bittar educates the listeners...
10/05/2023
Rheumatology & Arthritis
Vikas Majithia
Podcast
Vikas Majithia, MD, and Abhijeet Danve, MD, on Diagnosing AxSpA: Part 3
09/19/2023
In the third and final part of their podcast, Drs Majithia and Danve talk about tools now available to help clinicians confirm a diagnosis of axial spondyloarthritis.
In the third and final part of their podcast, Drs Majithia and Danve talk about tools now available to help clinicians confirm a diagnosis of axial spondyloarthritis.
In the third and final part of...
09/19/2023
Rheumatology & Arthritis
Vikas Majithia
Podcast
Vikas Majithia, MD, and Abhijeet Danve, MD, on Diagnosing AxSpA: Part 1
09/11/2023
Drs Majithia and Danve begin a 3-part podcast on diagnosing axial spondyloarthritis, including the roles of clinical judgment, imaging, and biomarkers.
Drs Majithia and Danve begin a 3-part podcast on diagnosing axial spondyloarthritis, including the roles of clinical judgment, imaging, and biomarkers.
Drs Majithia and Danve begin a...
09/11/2023
Rheumatology & Arthritis
Jean Liew
Podcast
Jean Liew, MD, on Disease Activity in Axial Spondyloarthritis During the Pandemic
06/14/2023
How have the stressors of the COVID-19 pandemic affected the patient-reported disease activity among individuals with axial spondyloarthritis (axSpA)? In this podcast, Jean Liew, MD, explains what she and her team discovered about the...
How have the stressors of the COVID-19 pandemic affected the patient-reported disease activity among individuals with axial spondyloarthritis (axSpA)? In this podcast, Jean Liew, MD, explains what she and her team discovered about the...
How have the stressors of the...
06/14/2023
Autoimmune
Laura Coates
Podcast
Laura Coates, MBChB, on Updates to GRAPPA Guidelines on PsA
05/12/2023
In this podcast, Dr Laura Coates of Oxford University discusses the changes made to the guidelines for treatment of psoriatic arthritis by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
In this podcast, Dr Laura Coates of Oxford University discusses the changes made to the guidelines for treatment of psoriatic arthritis by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.
In this podcast, Dr Laura Coates...
05/12/2023
Rheumatology & Arthritis
Vinod Chandran
Podcast
Can Depression Affect Disease Activity in Psoriatic Arthritis?
04/10/2023
Dr Vinod Chandran talks about his research into whether depression and anxiety can reduce the likelihood of achieving minimal disease activity in psoriatic arthritis.
Dr Vinod Chandran talks about his research into whether depression and anxiety can reduce the likelihood of achieving minimal disease activity in psoriatic arthritis.
Dr Vinod Chandran talks about...
04/10/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

In Partnership

Advertisement

Conference Coverage

News
Comparing Onset of Action of Therapies in Rheumatoid Arthritis
11/16/2024
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to...
11/16/2024
Rheumatology & Arthritis
Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial
12/12/2023
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial...
12/12/2023
Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis

Advertisement

Features

News
COVID-19 Vaccination and Gout Flares
01/24/2024
A recent study looked into the risk of increased gout flares among patients with infrequent flares after receiving their COVID-19 shots.
A recent study looked into the risk of increased gout flares among patients with infrequent flares after receiving their COVID-19 shots.
A recent study looked into the...
01/24/2024
Rheumatology & Arthritis
Feature
Evolving Treatment for Patients With BD
06/29/2021
Researchers suggest patients with Behçet disease receive careful attention to disease activity, and may require treatment adjustments.
Researchers suggest patients with Behçet disease receive careful attention to disease activity, and may require treatment adjustments.
Researchers suggest patients...
06/29/2021
Autoimmune
Research
Vascular Involvement in Behçet Disease
06/02/2021
Research reveals that vascular involvement was among top causes of hospitalization among patients with Behçet disease.
Research reveals that vascular involvement was among top causes of hospitalization among patients with Behçet disease.
Research reveals that vascular...
06/02/2021
Autoimmune
News
Measuring Physical Function of PsA
05/26/2021
Researchers reveal 2 assessment methods offering quality data in measuring physical function of patients with psoriatic arthritis.
Researchers reveal 2 assessment methods offering quality data in measuring physical function of patients with psoriatic arthritis.
Researchers reveal 2 assessment...
05/26/2021
Autoimmune
Feature
Determining Disease Severity in Patients With BD
05/11/2021
Inflammatory markers can be useful in determining disease severity among patients with Behçet disease, researchers revealed.
Inflammatory markers can be useful in determining disease severity among patients with Behçet disease, researchers revealed.
Inflammatory markers can be...
05/11/2021
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
In Behçet Disease, Sleep Plays Crucial Role in Patient-Reported Outcomes
02/05/2021
Lifestyle factors may influence the onset, disease course, and the severity of inflammation among patients with chronic and inflammatory disorders. What is the association of various lifestyle factors with self-rated wellness and health...
Lifestyle factors may influence the onset, disease course, and the severity of inflammation among patients with chronic and inflammatory disorders. What is the association of various lifestyle factors with self-rated wellness and health...
Lifestyle factors may influence...
02/05/2021
Autoimmune
Pop Quiz: Mesalamine Recommendations
Quiz
Pop Quiz: Mesalamine Recommendations
12/04/2020
Are you familiar with the American Gastroenterological Association’s recommendation on treatments for left-sided mild to moderate ulcerative proctosigmoiditis or proctitis? Take our pop quiz to find out.
Are you familiar with the American Gastroenterological Association’s recommendation on treatments for left-sided mild to moderate ulcerative proctosigmoiditis or proctitis? Take our pop quiz to find out.
Are you familiar with the...
12/04/2020
Autoimmune
News
Predictors of Cardiovascular Events in PsA Are Identified
10/14/2020
Could the Disease Activity in Psoriatic Arthritis index predict cardiovascular events among patients with psoriatic arthritis? Here is what new research has revealed.
Could the Disease Activity in Psoriatic Arthritis index predict cardiovascular events among patients with psoriatic arthritis? Here is what new research has revealed.
Could the Disease Activity in...
10/14/2020
Autoimmune
News
IL-12/23, IL-23 Antagonists Increase Risk of Upper Respiratory Tract Infections
08/28/2020
Findings from a recent study showed an increased risk for upper respiratory tract infections among patients treated with IL-12/23 or IL-23 antagonists.
Findings from a recent study showed an increased risk for upper respiratory tract infections among patients treated with IL-12/23 or IL-23 antagonists.
Findings from a recent study...
08/28/2020
Autoimmune
Optimizing Treatment Regimens in Immune-Mediated Diseases
Conference Coverage
Optimizing Treatment Regimens in Immune-Mediated Diseases
07/12/2020
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that...
07/12/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement